Recently joined the Nasdaq on 1/8/26 under new ticker $NGEN. I’m generally not a fan of pharma/biotech - and additionally, not typically non-U.S. pharma due to exchange rates, etc. (Headquartered in Vancouver, BC). However, I do like disruptive technology/applications, and they seem to advancing a breakthrough technology to treat spinal column injury and other neurological conditions. They also have licensing agreement with Case Western Reserve. Thoughts if you’re holding or are looking at? Thanks.